Pancreatic adenocarcinoma: An update

Journal of the American College of Surgeons

Volumn 183, Issue 2, 1996, Pages 164-184

  Tan, Henkie P ^a   Smith, James ^a   Garberoglio, Carlos A ^a  

^a LOMA LINDA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER DIAGNOSIS; CANCER GENETICS; CANCER INCIDENCE; CANCER RISK; CANCER STAGING; CARCINOGENESIS; CELL PROLIFERATION; DIABETES MELLITUS; DIAGNOSTIC APPROACH ROUTE; DISEASE ASSOCIATION; HEALTH BEHAVIOR; OCCUPATIONAL EXPOSURE; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROGNOSIS; RADIODIAGNOSIS; REVIEW; TREATMENT PLANNING;

ADENOCARCINOMA; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; DIAGNOSTIC IMAGING; HUMANS; PANCREATECTOMY; PANCREATIC NEOPLASMS;

EID: 0029785767     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (159)

1. Wingo, P. A. Cancer statistics, 1995. CA Cancer J. Clin., 1995, 45: 8-30.
2. Reber, H. A., Ashley, S. W., and McFadden, D. Curative treatments for pancreatic neoplasms: standard resection. Surg. Clin. North Am., 1995, 75: 905-912.
3. Brennan, M. F. Management of pancreatic cancer. Compr. Ther., 1995, 21: 25-28.
4. American Cancer Society. Cancer facts and figures 1994, 1995. New York: American Cancer Society, 1994, 1995.
5. Muir, C., Waterhouse, J., Mack, T., and others. Cancer Incidence in Five Continents. Vol. V. Lyon, France: International Agency for Research on Cancer, 1988. (IARC Scientific Publication No. 88.)
6. Fernandez, E., La Vecchia, C., Porta, M., and others. Trends in pancreatic cancer mortality in Europe, 1955-1989. Int. J. Cancer, 1994, 57: 786-792.
7. Satake, K., Takeuchi, T., Homma, T., and Ozaki, H. CA 19-9 as a screening and diagnostic tool in symptomatic patients: the Japanese experience. Pancreas, 1994, 9: 703-706.
8. Lillemoe, K. D. Pancreatic disease in the elderly patient. Surg. Clin. North Am., 1994, 74: 317-344.
9. National Cancer Institute. SEER cancer statistics review, 1973-1990. Bethesda, MD: Department of Health and Human Services, 1993. (NIH Publication No. 93-2789.)
10. Lynch, H. T. Genetics and pancreatic cancer. Arch. Surg., 1994, 129: 266-268.
11. Ghadirian, P., Boyle, P., Simard, A., and others. Reported family aggregation of pancreatic cancer within a population-based case-control study in the Franco-phone community in Montreal, Canada. Int. J. Pancreatol., 1991, 10: 183-196.
12. Partanen, T., Kauppinen, T., Degerth, R., and others. Pancreatic cancer in industrial branches and occupations in Finland. Am. J. Ind. Med., 1994, 25: 851-866.
13. Poston, G. J., Gillespie, J., and Guillou, P. J. Biology of pancreatic cancer. Gut, 1991, 32: 800-812.
14. Vezeridis, M. P., and Wanebo, H. J. Pancreatic cancer in 1994: diagnosis and treatment. R. I. Med., 1994, 77: 115-118.
15. Gold, E. B. Epidemiology of and risk factors for pancreatic cancer. Surg. Clin. North Am., 1995, 75: 819-843.
16. Silverman, D. T., Dunn, J. A., Hoover, R. N., and others. Cigarette smoking and pancreas cancer: a case-control study based on direct interviews. J. Natl. Cancer Inst., 1994, 86: 1510-1515.
17. Gordis, L. Consumption of methylxanthine-containing beverages and risk of pancreatic cancer. Cancer Lett., 1990, 52: 1-12.
18. Ghadirian, P., and Howe, G. R. Nutrition, alcohol, coffee, and pancreatic cancer. Int. J. Pancreatol., 1994, 16: 204-207.
19. Shibata, A., Mack, T. M., Paganini-Hill, A., and others. A prospective study of pancreatic cancer in the elderly. Int. J. Cancer, 1994, 58: 46-49.
20. Howard, J. M. Pancreatitis as a predisposing factor for pancreatic cancer. Int. J. Pancreatol., 1994, 16: 207-210.
21. Lowenfels, A. B., Maisonneuve, P., Cavallini, G., and others. Pancreatitis and the risk of pancreatic cancer: International Pancreatitis Study Group. N. Engl J. Med., 1993, 328: 1433-1437.
22. Gold, E. B., and Cameron, J. L. Chronic pancreatitis and pancreatic cancer. N. Engl. J. Med., 1993, 328: 1485-1486.
23. Ekbom, A., McLaughlin, J. K., Karlsson, B. M., and others. Pancreatitis and pancreatic cancer: a population based study. J. Natl. Cancer Inst., 1994, 86: 625-627.
24. Fernandez, E., La Vecchia, C., Porta, M., and others. Pancreatitis and the risk of pancreatic cancer. Pancreas, 1995, 11: 185-189.
25. Permert, J., Ihse, I., Jorfledt, L., and others. Pancreatic cancer is associated with impaired glucose metabolism. Eur. J. Surg., 1993, 159: 101-107.
26. Adrian, T. E., Permert, J., and Westermark, G. T. Islet hormones in pancreatic cancer: the association between islet amyloid polypeptide levels and diabetes. Int. J. Pancreatol., 1994, 16: 274-277.
27. Pour, P. M. Strategies that might be feasible for early intervention in pancreatic cancer. Int. J. Pancreatol., 1994, 16: 186-189.
28. Gullo, L., Pezzilli, R., Morselli-Labate, A. M., and the Italian Pancreatic Cancer Study Group. Diabetes and the risk of pancreatic cancer. N. Engl. J. Med., 1994, 331: 81-84.
29. Balkau, B., Barrett-Connor, E., Eschwege, E., and others. Diabetes and pancreatic carcinoma. Diabetes Metab., 1993, 19: 458-462.
30. Balkau, B., Barrett-Connor, E., and Eschwege, E. Pancreatic cancer and diabetes. N. Engl. J. Med., 1994, 331: 1526-1528.
31. Everhart, J., and Wright, D. Diabetes mellitus as a risk factor for pancreatic cancer: a meta-analysis. J. A. M. A., 1995, 273: 1605-1609.
32. Noy, A., and Bilezikian, J. P. Diabetes and pancreatic cancer: clues to the early diagnosis of pancreatic malignancy. J. Clin. Endocrinol. Metab., 1994, 79: 1223-1231.
33. Warshaw, A. L., and Fernandez-del Castillo, C. Pancreatic carcinoma. N. Engl. J. Med., 1992, 326: 455-465.
34. Giardiello, F. M., Offerhaus, G. J. A., Lee, D. H., and others. Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis. Gut, 1993, 34: 1394-1396.
35. Cubilla, A. L., and Fitzgerald, P. J. Tumors of the exocrine pancreas. Atlas of tumor pathology. 2nd series. Fascicle 19. Washington, D.C.: Armed Forces Institute of Pathology, 1984.
36. Kelly, D. M., and Benjamin, I. S. Pancreatic carcinoma. Ann. Oncol., 1995, 6: 19-28.
37. Reznek, R. H., and Stephens, D. H. The staging of pancreatic adenocarcinoma. Clin. Radiol., 1993, 47: 373-381.
38. Mao, C., Domenico, D. R., Kim, K., and others. Observations on the developmental patterns and the consequences of pancreatic exocrine adenocarcinoma. Arch. Surg., 1995, 130: 125-134.
39. Hruban, R. H., van Mansfeld, A. D., Offerhaus, G. J., and others. K-ras oncogene activation in adenocarcinoma of the human pancreas. Am. J. Pathol., 1993, 143: 545-554.
40. Sakorafas, G. H., and Tsiotou, A. G. Genetic basis of cancer of the pancreas: diagnostic and therapeutic applications. Eur. J. Surg., 1994, 160: 529-534.
41. Scarpelli, D. G. Genetic events in carcinogenesis and pancreatic cell differentiation: what we need to know. Int. J. Pancreatol., 1994, 16: 189-192.
42. Trumper, L. H., Burger, B., von Bonin, F., and others. Diagnosis of pancreatic adenocarcinoma by polymerase chain reaction from pancreatic secretions. Br. J. Cancer, 1994, 70: 278-284.
43. Adrian, T. E. Prognostic potential of oncogenes and tumor-suppressor genes in pancreatic cancer. Int. J. Pancreatol., 1994, 16: 227-229.
44. Hall, P. A., Hughes, C. M., Staddon, S. L., and others. The c-erb B-2 proto-oncogene in human pancreatic cancer. J. Pathol., 1990, 161: 195-200.
45. Ruggeri, B. A., Klein-Szanto, A. J. P., Huang, L. Y., and Lang D. p53 and RB-1 tumor-suppressor gene expression and alterations in human pancreatic cancer: a review of the literature and ongoing studies. Int. J. Pancreatol., 1994, 16: 193-196.
46. Yamanaka, Y., Friess, H., Kobrin, M. S., and others. Overexpression of HER2/neu oncogene in human pancreatic carcinoma. Hum. Pathol., 1993, 24: 1127-1134.
47. Lumadue, J. A., Griffin, C. A., Osman, M., and Hruban, R. H. Surg. Clin. North Am., 1995, 75: 845-855.
48. Andren-Sandberg, A., and Johansson, B. Chromosomal abnormalities in exocrine pancreatic carcinomas. Int. J. Pancreatol., 1994, 16: 196-198.
49. Seymour, A. B., Hruban, R. H., Redstone, M., and others. Allelotype of pancreatic adenocarcinoma. Cancer Res., 1994, 54: 2761-2764.
50. Hahn, S. A., and Kern, S. E. Molecular genetics of exocrine pancreatic neoplasms. Surg. Clin. North Am., 1995, 75: 857-869.
51. Caldas, C., Hahn, S. A., da Costa, L. T., and others. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nat. Genet., 1994, 8: 27-32.
52. Korc, M. Growth factors, receptors, and regulation: normal and malignant. Int. J. Pancreatol., 1994, 16: 234-236.
53. Korc, M. Kinases, phosphatases, oncogenes, and tumor-suppressor genes. Int. J. Pancreatol., 1994, 16: 268-271.
54. Watanabe, N., Yamauchi, N., Maeda, M., and others. Recombinant human tumor necrosis factor causes regression in patients with advanced malignancies. Oncology, 1995, 51: 360-365.
55. Bold, R. J., Evers, B. M., Sperling, H. E., and others. Gastrointestinal hormone receptors and pancreatic cancer. Int. J. Pancreatol., 1994, 16: 240-241.
56. Schally, A. V., Szepeshazi, K., Qin, Y., and others. Antitumor effects of analogs of somatostatin and antagonists of bombesin/GRP in experimental models of pancreatic cancer. Int. J. Pancreatol., 1994, 16: 246-249.
57. Murr, M. M., Sarr, M. G., Oishi, A. J., and van Heerden, J. A. Pancreatic cancer. CA Cancer J. Clin., 1994, 44: 304-318.
58. Ariyama, J. Abnormal glucose tolerance in patients with early pancreatic carcinoma. Int. J. Pancreatol., 1994, 16: 91-91.
59. Lillemoe, K. D. Current management of pancreatic carcinoma. Ann. Surg., 1995, 221: 133-148.
60. Moosa, A. R., and Gamagami, R. A. Diagnosis and staging of pancreatic neoplasms. Surg. Clin. North Am., 1995, 75: 871-890.
61. DiMagno, E. P. Preoperative staging of pancreatic ductal cancer in the USA. Int. J. Pancreatol., 1994, 16: 112-114.
62. Rosch, T., Braig, C., Gain, T., and others. Staging of pancreatic and ampullary carcinoma by endoscopic ultrasonography: comparison with conventional sonography, computed tomography, and angiography. Gastroenterology, 1992, 102: 188-199.
63. Freeny, P. C., Traverso, L. W., and Ryan, J. A. Diagnosis and staging of pancreatic adenocarcinoma with dynamic computed tomography. Am. J. Surg., 1993, 165: 600-616.
64. Wyatt, S. H., and Fishman, E. K. Spiral CT of the pancreas. Semin. Ultrasound CT MR, 1994, 15: 122-132.
65. Nghiem, H. V., and Freeny, P. C. Radiologic staging of pancreatic adenocarcinoma. Radiol. Clin. North Am., 1994, 32: 71-79.
66. Aoki, K., Okada, S., Moriyama, N., and others. Accuracy of computed tomography in determining pancreatic cancer tumor size. Jpn. J. Clin. Oncol., 1994, 24: 85-87.
67. Ballard, R. B, Hoffman, J. P., Guttman, M. C., and others. How accurate is size measurement of pancreas cancer masses by computed axial tomography (CT) scanning. Am. Surg., 1995, 61: 686-691.
68. Robins, D. B., Katz, R. L., Evans, D. B., and others. Fine needle aspiration of the pancreas: in quest of accuracy. Acta Cytol., 1995, 39: 1-10.
69. Nakamura, R., Machado, R., Amikura, K., and others. Role of fine needle aspiration cytology and endoscopic biopsy in the preoperative management of pancreatic and peripancreatic malignancies. Int. J. Pancreatol., 1994, 16: 17-21.
70. Nakaizumi, A., Uehara, H., Iishi, H., and others. Endoscopic ultrasonography in diagnosis and staging of pancreatic cancer. Dig. Dis. Sci., 1995, 40: 696-700.
71. Lightdale, C. J. Endosonography for evaluating pancreatic mass lesions. Int. J. Pancreatol., 1994, 16: 261-264.
72. Palazzo, L., Roseau, G., Gayet, B., and others. Endoscopic ultrasonography in the diagnosis and staging of pancreatic adenocarcinoma: results of a prospective study with comparison to ultrasonography and CT scan. Endoscopy, 1993, 25: 143-150.
73. Yasuda, K., Mukai, H., Nakajima, M., and Kawai, K. Staging of pancreatic carcinoma by endoscopic ultrasonography. Endoscopy, 1993, 25: 151-155.
74. Rosch, T., Lorenz, R., Braig, C., and others. Endoscopic ultrasonography. Gastrointest. Endosc., 1991, 37: 347-352.
75. Biehl, T. R., Traverso, W., Hauptmann, E., and Ryan Jr., J. A. Preoperative visceral angiography alters intraoperative strategy during the Whipple procedure. Am. J. Surg., 1993, 165: 607-612.
76. Megibow, A. J., Zhou, X. H., Rotterdam, H., and others. Pancreatic adenocarcinoma: CT versus MR imaging in the evaluation of resectability - Report of the Radiology Diagnostic Oncology Group. Radiology, 1995, 195: 327-332.
77. Kaneko, T., Nakao, A., Harada, A., and others. Intraportal endovascular ultrasonography in pancreatic cancer - A new technique for the diagnosis of portal vein invasion: a preliminary report. Surgery, 1994, 115: 438-444.
78. Gullo, L. CA 19-9: The Italian experience. Pancreas, 1994, 9: 717-919.
79. Satake, K., and Takeuchi, T. Comparison of CA 19-9 with other tumor markers in the diagnosis of cancer of the pancreas. Pancreas, 1994, 9: 720-724.
80. Lundin, J., Roberts, P. J., Kuusela, P., and Haglund, C. The prognostic value of preoperative serum levels of CA 19-9 and CEA in patients with pancreatic cancer. Br. J. Cancer, 1994, 69: 515-519.
81. Ritts Jr., R. E., Nagorney, D. M., Jacobsen, D. J., and others. Comparison of preoperative serum CA 19-9 levels with results of diagnostic imaging modalities in patients undergoing laparotomy for suspected pancreatic or gallbladder disease. Pancreas, 1994, 9: 707-716.
82. Forsmark, C. E., Lambiase, L., and Vogel, S. B. Diagnosis of pancreatic cancer and prediction of unresectability using the tumor-associated antigen CA 19-9. Pancreas, 1994, 9: 731-734.
83. Haglund, C., Lundin, J., Kuusela, P., and Roberts, P. J. CA 242, a new tumour marker for pancreatic cancer: a comparison with CA 19-9, CA 50 and CEA. Br. J. Cancer, 1994, 70: 487-492.
84. Pasanen, P. A., Eskelinen, M., Partanen, K., and others. A prospective study of serum tumor markers, carcinoembryonic antigen, carbohydrate antigens 50 and 242, tissue polypeptide antigen and tissue polypeptide specific antigen in the diagnosis of pancreatic cancer with special reference to multivariate diagnostic score. Br. J. Cancer, 1994, 69: 562-565.
85. Nitecki, S. S., Sarr, M. G., Colby, T. V., and van Heerden, J. A. Long-term survival after resection for ductal adenocarcinoma of the pancreas: is it really improving. Ann. Surg., 1995, 221: 59-66.
86. Cameron, J. L., Crist, D. W., Sitzman, J. V., and others. Factors influencing survival following pancreaticoduodenectomy for pancreatic cancer. Am. J. Surg., 1991, 161: 120-125.
87. Eskelinen, M., and Lipponen, P. A review of prognostic factors in human pancreatic adenocarcinoma. Cancer Detect. Prev., 1992, 16: 287-295.
88. Bottger, T. C., Storkel, S., Wellek, S., and others. Factors influencing survival after resection of pancreatic cancer. Cancer, 1994, 73: 63-73.
89. Linder, S., Falkmer, U., Hagmar, T., and others. Prognostic significance of DNA ploidy in pancreatic carcinoma. Pancreas, 1994, 9: 764-772.
90. Warshaw, A. L. Prevalence and patterns of spread in early pancreatic adenocarcinoma. Int. J. Pancreatol., 1994, 16: 225-227.
91. Takahashi, S., Ogata, Y., and Tsuzuki, T. Combined resection of the pancreas and portal vein for pancreatic cancer. Br. J. Surg., 1994, 81: 1190-1193.
92. Fernandez-del Castillo, C., Rattner, D. W., and Warshaw, A. L. Further experience with laparoscopy and peritoneal cytology in the staging of pancreatic cancer. Br. J. Surg., 1995, 82: 1127-1129.
93. Lillemoe, K. D., and Barnes, S. A. Surgical palliation of unresectable pancreatic carcinoma. Surg. Clin. North Am., 1995, 75: 953-968.
94. Unio International Contra Cancrum: TNM Classification of Malignant Tumors. 4th ed., 2nd rev. Edited by P. Hermanek and L. H. Sobin. Berlin: Springer Verlag, 1992.
95. American Joint Committee on Cancer: Manual for Staging of Cancer. Edited by O. H. Beahrs, D. E. Henson, R. V. P. Hutter, and B. J. Kennedy. 4th ed. Philadelphia: Lippincott Co., 1992.
96. Japan Pancreas Society. General Rules for the Study of Pancreatic Cancer. 4th ed. Tokyo: Kanehara Shuppan, 1993.
97. Zerbi, A., Balzano, G., Bottura, R., and Di Carlo, V. Reliability of pancreatic cancer staging classifications. Int. J. Pancreatol., 1994, 15: 13-18.
98. Tsunoda, T., Eto, T., and Tsuchiya, R. Clinical comparison of UICC and Japanese classifications: Japanese experience. Int. J. Pancreatol., 1994, 16: 105-108.
99. Hermanek, P., Wittekind, C., and Altendorf-Hofmann, A. UICC classification of pancreatic ductal adenocarcinoma. Int. J. Pancreatol., 1994, 16: 230-232.
100. Reber, H. A. Pancreatic cancer. Necessity for a revised staging classification. Int. f. Pancreatol., 1994, 16: 232-234.
101. Yamamoto, M., Ohashi, O., Ishida, H., and others. Relationship between survival and cancer extension. Int. J. Pancreatol., 1994, 15: 118-120.
102. Cameron, J. L., Pitt, H. A., Yeo, C. J., and others. One hundred and forty-five consecutive pancreaticoduodenectomies without mortality. Ann. Surg., 1993, 217: 430-438.
103. Cameron, J. L. Long-term survival following pancreaticoduodenectomy for adenocarcinoma of the head of the pancreas. Surg. Clin. North Am., 1995, 75: 939-951.
104. Morgagni, G. B. The seats and causes of diseases. Translated by B. Alexander. New York: Hafner Publishing Co. for the library of the New York Academy of Medicine, 1769.
105. von Winiwarter, A. Fall von Gallenretention bedingt durch Impermeabilität des Ductus choledochus. Prag. med. Wchnschr, 1882, 7: 201-213.
106. Kausch, W. Das Carcinom der Papilla duodenia und seine radikale Entfernung. Beitr. z. klin. Chir., 1912, 78: 439-486.
107. Brunschwig, A. Resection of head of pancreas and duodenum for carcinoma - pancreatoduodenectomy. Surg. Gynecol. Obstet., 1937, 65: 681-684.
108. Bassin, A., and O'Leary, J. P. The first report of a successful pancreaticoduodenectomy. Am. Surg., 1995, 61: 845-846.
109. Pitt, H. A. Curative treatments for pancreatic neoplasms: standard resection. Surg. Clin. North Am., 1995, 75: 891-904.
110. Yeo, C. J., Cameron, J. L., Lillemoe, K. D., and others. Pancreaticoduodenectomy for cancer of the head of the pancreas: 201 patients. Ann. Surg., 1995, 221: 721-733.
111. Watson, K. Carcinoma of the ampulla of Vater: successful radical resection. Br. J. Surg., 1944, 31: 368-373.
112. Traverso, L. W., and Longmire, W. P. Preservation of the pylorus in pancreaticoduodenectomy. Ann. Surg., 1980, 192: 306-310.
113. Patel, A. G., Toyoma, M. T., Kusske, A. M., and others. Pylorus-preserving Whipple resection for pancreatic cancer. Arch. Surg., 1995, 130: 838-843.
114. Lillemoe, K. D., Cameron, J. L., Kaufman, H. S., and others. Chemical splanchnicectomy in patients with unresectable pancreatic cancer. Ann, Surg., 1993, 217: 447-457.
115. Fortner, J. G. Regional resection of cancer of the pancreas: a new surgical approach. Surgery, 1973, 73: 307-320.
116. Swope, T. J., Wade, T. P., Neuberger, T. J., and others. A reappraisal of total pancreatectomy for pancreatic cancer: results from U.S. Veterans Affairs hospitals, 1987-1991. Am. J. Surg., 1994, 168: 582-586.
117. Johnson, C. D., Schwall, G., Flechtenmacher, J., and Trede, M. Resection for adenocarcinoma of the body and tail of the pancreas. Br. J. Surg., 1993, 80: 1177-1179.
118. McLeod, R. S., Taylor, B. R., O'Connor, B. I., and others. Quality of life, nutritional status, and gastrointestinal hormone profile following the Whipple procedure. Am. J. Surg., 1995, 169: 179-185.
119. Yeo, C. J. Management of complications following pancreaticoduodenectomy. Surg. Clin. North Am., 1995, 75: 913-924.
120. Fernandez-del Castillo, C., Rattner, D. W., and Warshaw, A. L. Standards for pancreatic resection. Arch. Surg., 1995, 130: 295-300.
121. Brennan, M. F., Pisters, P. W., Posner, M., and others. A prospective randomized trial of total parenteral nutrition after major pancreatic resection for malignancy. Ann. Surg., 1994, 220: 436-444.
122. Trede, M., Schwall, G., and Saeger, H. D. Survival after pancreatoduodenectomy - 118 consecutive resections without an operative mortality. Ann. Surg., 1990, 211: 447-458.
123. Wade, T. P., el-Ghazzawy, A. G., Virgo, K. S., and Johnson, F. E. The Whipple resection for cancer in U.S. Department of Veterans Affairs Hospital. Ann. Surg., 1995, 221: 241-248.
124. Sarr, M. G., and Cameron, J. L. Surgical management of unresectable carcinoma of the pancreas. Surgery, 1982, 91: 123-133.
125. Bakkevold, K. E., and Kambestad, B. Morbidity and mortality after radical and palliative pancreatic cancer surgery: risk factors influencing the short-term results. Ann. Surg., 1993, 217: 356-368.
126. Egrari, S., and O'Connell, T. X. Role of prophylactic gastroenterostomy for unresectable pancreatic carcinoma. Am. Surg., 1995, 61: 862-864.
127. Lichtenstein, D. R., and Carr-Loke, D. L. Endoscopic palliation for unresectable pancreatic carcinoma. Surg. Clin. North Am., 1995, 75: 969-988.
128. Kaufman, S. L. Percutaneous palliation of unresectable pancreatic cancer. Surg. Clin. North Am., 1995, 75: 989-999.
129. O'Brien, S., Hatfield, A. R., Craig, P. I., and William, S. P. A three year follow up of self expanding metal stents in the endoscopic palliation of longterm survivors with malignant biliary obstruction. Gut, 1995, 36: 618-621.
130. Pitt, H. A., Gomes, A. S., Lois, J. F., and others. Does preoperative percutaneous biliary drainage reduces operative risk or increase hospital cost? Ann. Surg., 1985, 201: 545-553.
131. Lygidakis, N. J., van der Heyde, M. N., and Lubbers, M. J. An evaluation of preoperative biliary drainage in the surgical management of pancreatic head carcinoma. Acta Chir. Scand., 1987, 153: 665-668.
132. Lai, E. C. S., Mok, F. P. T., Fan, S. T., and others. Preoperative endoscopic drainage for malignant obstructive jaundice. Br. J. Surg., 1994, 81: 1195-1198.
133. Proctor, H. J., and Mauro, M. Biliary diversion for pancreatic carcinoma: matching the methods and the patient. Am. J. Surg., 1990, 159: 67-71.
134. Sharfman, W. H., and Walsh, T. D. Has the analgesic efficacy of neurolytic celiac plexus block been demonstrated in pancreatic cancer pain? Pain, 1990, 41: 267-271.
135. Evans, D. B., Termuhlen, P. M., Byrd, D. R., and others. Intraoperative radiation therapy following pancreatoduodenectomy. Ann. Surg., 1993, 1: 54-60.
136. Abrams, R. A., and Grochow, L. B. Adjuvant therapy with chemotherapy and radiation therapy in the management of carcinoma of the pancreatic head. Surg. Clin. North Am., 1995, 75: 925-938.
137. Willett, C. G., Lewandrowski, K., Warshaw, A. L., and others. Resection margins in carcinoma of the head of the pancreas. Ann. Surg., 1993, 217: 144-148.
138. Neoptolemos, J. P., and Kerr, D. J. Adjuvant therapy for pancreatic cancer. Br. J. Surg., 1995, 82: 1012-1014.
139. Heijmans, H. J., Hoekstra, H. J., and Mehta, D. M. Is adjuvant intraoperative radiotherapy (IORT) for resectable and unresectable pancreatic carcinoma worthwhile? Hepatogastroenterology, 1989, 36: 474-477.
140. Zerbi, A., Fossati, V., Parolini, D., and others. Intraoperative radiation therapy adjuvant to resection in the treatment of pancreatic cancer. Cancer, 1994, 73: 2930-2935.
141. Hiraoka, T., Uchino, R., Kanemitsu, K., and others. Combination of intraoperative radiation with resection of cancer of the pancreas. Int. J. Pancreatol., 1990, 7: 201-207.
142. Kasperk, R., Klever, P., Andreopulos, D., and Schumpelick, V. Intraoperative radiotherapy for pancreatic carcinoma. Br. J. Surg., 1995, 82: 1259-1261.
143. Dobelbower, R. R., Wagner, S. M., Fadell, R. J., and others. Pancreatic cancer. In: Gastrointestinal Cancer: Radiation Therapy. Edited by R. R. Dobelbower. Pp. 115-148. Hamburg, Germany: Springer-Verlag, 1990.
144. Dobelbower, R. R. Radiation therapy for cancer of the pancreas alone or combined with surgery and/or chemotherapy state of the art - 1994. Int. J. Pancreatol., 1994, 16: 294-296.
145. Kalser, M., and Ellenberg, S. Pancreatic cancer adjuvant combined radiation and chemotherapy following curative resection. Arch. Surg., 1985, 120: 899-903.
146. Gastrointestinal Tumor Study Group. Further evidence of effective combined radiation and chemotherapy following curative resection of pancreatic cancer. Cancer, 1987, 59: 2006-2010.
147. Hoffman, J. P., Weese, J. L., Solin, L. J., and others. A pilot study of preoperative chemoradiation for patients with localized adenocarcinoma of the pancreas. Am. J. Surg., 1995, 169: 71-78.
148. Ishikawa, O., Ohhigashi, H., Teshima, T., and others. Clinical and histopathological appraisal of preoperative irradiation for adenocarcinoma of the pancreaticoduodenal region. J. Surg. Oncol., 1989, 40: 143-151.
149. Dalton, R., Hoffman, J., Barber, L., and Eisenberg, B. Influence of prior operative assessment and angiographic findings on resectability and survival in adenocarcinoma of the pancreas treated with preoperative chemoradiation. (Abstract). P. 23. 47th Annual Cancer Symposium, Society of Surgical Oncology, Houston, March 17-20, 1994.
150. Jessup, J. M., Steele Jr., G., Mayer, R. J., and others. Neoadjuvant therapy for unresectable pancreatic adenocarcinoma. Arch. Surg., 1993, 128: 559-564.
151. Mohiuddin, M., Rosato, F., Barbot, D., and others. Long-term results of combined modality treatment with 1-125 implantation for carcinoma of the pancreas. Int. J. Radiat. Oncol. Biol. Phys., 1992, 23: 305-311.
152. Wagener, D. J., de Mulder, P. H., and Wils, J. A. Multimodality treatment of locally advanced pancreatic cancer. Ann. Oncol., 1994, Suppl. 3, 5: 81-86.
153. Casper, E. S. Chemotherapy for pancreas cancer. Int. J. Pancreatol., 1994, 16: 296-298.
154. Kelsen, D. The use of chemotherapy in the treatment of advanced gastric and pancreas cancer. Semin. Oncol., 1994, 4 Suppl. 7, 21: 58-66.
155. Bruckner, H. W., Kalnicki, S., Dalton, J., and others. Survival after combined modality therapy for pancreatic cancer. J. Clin. Gastroenterol., 1993, 16: 199-203.
156. Palmer, K. R., Kerr, M., Knowles, G., and others. Chemotherapy prolongs survival in inoperable carcinoma. Br. J. Surg., 1994, 81: 882-885.
157. Nightingale, S. L. Treatment IND for advanced pancreatic cancer authorized. J. A. M. A., 1995, 273: 982.
158. Tempero, M., and Colcher, D. An overview of monoclonal-based therapy in pancreatic cancer. Int. J. Pancreatol., 1994, 16: 300-302.
159. Moesta, K. T., Schlag, P., Douglass Jr., H. O., and Mang, T. S. Evaluating the role of photodynamic therapy in the management of pancreatic cancer. Lasers Surg. Med., 1995, 16: 84-92.